play_arrow
Jamz 103.3
Lady Gaga defended her love for 'Harlequin' after a fan playfully called her out for not including the album in her Coachella set. Lady Gaga defended her love for 'Harlequin' after a fan playfully called her out for not including the album in her Coachella set. Read More
Sheryl Crow and LeAnn Rimes will serve as 'The Voice' mega mentors for season 27. Sheryl Crow and LeAnn Rimes will serve as 'The Voice' mega mentors for season 27. Read More
It's not easy to perform a Jelly Roll song in front of the artist himself, but 'American Idol' contestant Jamal Roberts excelled at the challenge. It's not easy to perform a Jelly Roll song in front of the artist himself, but 'American Idol' contestant Jamal Roberts excelled at the challenge. Read More
Billboard JAPAN talked to Yu Sakai about his hopes for his new album, 'PASADENA,' as well as his Tiny Desk Concerts debut. Billboard JAPAN talked to Yu Sakai about his hopes for his new album, 'PASADENA,' as well as his Tiny Desk Concerts debut. Read More
Benson Boone took to TikTok to poke fun at the Coachella crowd's reaction to Queen's Brian May joining him onstage as a surprise guest. Benson Boone took to TikTok to poke fun at the Coachella crowd's reaction to Queen's Brian May joining him onstage as a surprise guest. Read More
Taxpayers in Tennessee, Arkansas will have more time to file their taxes as the IRS accommodates victims of the severe storms this month. Taxpayers in Tennessee, Arkansas will have more time to file their taxes as the IRS accommodates victims of the severe storms this month. Read More
As the second half of the Top 24 performed, Mattie Pruitt slayed a Katy Perry cover and Amanda Barise impressed her first crush, Josh Groban. As the second half of the Top 24 performed, Mattie Pruitt slayed a Katy Perry cover and Amanda Barise impressed her first crush, Josh Groban. Read More
Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing.Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. Read More
